IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v6y2015i1d10.1038_ncomms9683.html
   My bibliography  Save this article

A mutational signature in gastric cancer suggests therapeutic strategies

Author

Listed:
  • Ludmil B. Alexandrov

    (Cancer Genome Project, Wellcome Trust Sanger Institute
    Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory
    Center for Nonlinear Studies, Los Alamos National Laboratory)

  • Serena Nik-Zainal

    (Cancer Genome Project, Wellcome Trust Sanger Institute
    Addenbrooke’s Hospital National Health Service (NHS) Trust)

  • Hoi Cheong Siu

    (The University of Hong Kong, Queen Mary Hospital)

  • Suet Yi Leung

    (The University of Hong Kong, Queen Mary Hospital)

  • Michael R Stratton

    (Cancer Genome Project, Wellcome Trust Sanger Institute)

Abstract

Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure of double-strand DNA break repair by homologous recombination based on its high mutational burden in samples harbouring BRCA1 or BRCA2 mutations. In pancreatic cancer, all responders to platinum therapy exhibit this mutational signature including a sample that lacked any defects in BRCA1 or BRCA2. Here, we examine 10,250 cancer genomes across 36 types of cancer and demonstrate that, in addition to breast, ovarian and pancreatic cancers, gastric cancer is another cancer type that exhibits this mutational signature. Our results suggest that 7–12% of gastric cancers have defective double-strand DNA break repair by homologous recombination and may benefit from either platinum therapy or PARP inhibitors.

Suggested Citation

  • Ludmil B. Alexandrov & Serena Nik-Zainal & Hoi Cheong Siu & Suet Yi Leung & Michael R Stratton, 2015. "A mutational signature in gastric cancer suggests therapeutic strategies," Nature Communications, Nature, vol. 6(1), pages 1-7, December.
  • Handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9683
    DOI: 10.1038/ncomms9683
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms9683
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms9683?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jurica Levatić & Marina Salvadores & Francisco Fuster-Tormo & Fran Supek, 2022. "Mutational signatures are markers of drug sensitivity of cancer cells," Nature Communications, Nature, vol. 13(1), pages 1-19, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9683. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.